GMM Pfaudler Group appoints Gregory Gelhaus as Chief Transformation Officer
Gelhaus has a proven track record of driving business growth
Gelhaus has a proven track record of driving business growth
Priced at just Rs. 499 for 1-year supply, this initiative is aligned with the vision of Health for All
The transaction structured as share swap, is valued at ~Rs. 849 crore, with no cash outflow
Planned acquisition will strengthen the presence of Merck Healthcare in the United States and expand reach of SpringWorks’ therapeutic innovations to more patients with rare tumors worldwide
The capital raise will also support debt repayment or prepayment, improving the company's debt-to-equity ratio and overall financial resilience
Strengthening capabilities in Peptide Therapeutics and CDMO services
These appointments align with the group’s philosophy of having a strong and independent board with exceptional industry experts, ensuring strategic guidance and effective governance
Havix was incorporated under the laws of the State of Delaware on February 17, 2015
Investment will fund expansion to meet rising demand for CRDMO services
These initiatives will strengthen the company’s capital base, providing financial flexibility for future
Subscribe To Our Newsletter & Stay Updated